Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for Screening

Abstract

Prenatal screening of serum to generate individual estimates of the risk of Down's syndrome in the fetus can provide a basis for decision making in the cases of women 35 years of age or older, as it does in younger pregnant women, and is an alternative to current testing practices.